Dr Reddy's launches Vigabatrin oral powder in US market: The company launched Vigabatrin Powder for oral solution, USP in 500 mg per packet, a therapeutic equivalent generic version of Sabril powder for oral solution, USP, approved by the US Food and Drug Administration.
Shares of Kwality touched 52-week low of Rs 2.19, down 4.3 percent on August 20 as company's losses widened in the quarter ended June 2019. The company's Q1FY20 loss was at Rs 64.6 crore against loss of Rs 0.85 crore in a year ago period.
Shares of Kwality touched 52-week low of Rs 2.19, down 4.3 percent on August 20 as company's losses widened in the quarter ended June 2019. The company's Q1FY20 loss was at Rs 64.6 crore against loss of Rs 0.85 crore in a year ago period.
No comments:
Post a Comment